LACOSAMIDE
NDC 50228-195, LACOSAMIDE, tablet, film coated, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-195
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205237
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/50228-195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-195-10 | 50228019510 | 1000 TABLET, FILM COATED in 1 BOTTLE (50228-195-10) |
| 50228-195-30 | 50228019530 | 30 TABLET, FILM COATED in 1 BOTTLE (50228-195-30) |
| 50228-195-60 | 50228019560 | 60 TABLET, FILM COATED in 1 BOTTLE (50228-195-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f4ffa3ad-1278-4772-9ef8-ed6fdaa47605NADAC price for package 50228019560
GET /v1/drugs/nadac/50228019560
Use it
Look up 50228-195 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-195. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.